Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
aap Implantate AG is a medical technology company based in Berlin, Germany, specializing in the development, manufacturing, and marketing of trauma products for orthopedics. Its core offerings include the LOQTEQ® anatomical plating system and a range of cannulated screws designed for fracture treatment. The company is also advancing technologies such as antibacterial silver coating and magnesium-based implants to address unmet needs in trauma care. Founded in 1990, aap Implantate AG operates directly in Germany and through a network of distributors in approximately 25 countries, with a hybrid distribution strategy in the United States via its subsidiary, aap Implants Inc. In 2023, the company established a research and development and production headquarters in Suzhou New District, China, to conduct clinical trials on high-end silver ion anti-infection implants. This strategic expansion aims to enhance its presence in the Chinese market and leverage the region's favorable business environment.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
aap Implantate AGEli Lilly
Last price
€1.40$1,427.28
Currency
EUR
USD
€19M$1.3T
-46.65
-€0.19$30.81
0.280.39
0$6.69
00.48%
Sector
HealthHealth
Employees
10550,000
Ticker
€AAQ1$LLY
Primary listing
XETRANYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €AAQ1 or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.